Blood cancers

News in brief: Genome testing funded for MM and CLL patients; ISBT Congress cancelled; Nutrition guidelines for cancer patients;

Genome testing funded for MM and CLL patients The 2021 federal Budget has included an announcement of $2.9 million funding for genetic testing for people with multiple myeloma and chronic lymphocytic leukaemia. The move is expected to provide genome-wide microarray testing (GWMA) for 13,500 patients. Funding was recommended by the Medicare Services Advisory Committee (MSAC) ...

Already a member?

Login to keep reading.

© 2021 the limbic